CAM
WST icon

CGOV Asset Management’s West Pharmaceutical WST Stock Holding History

CGOV Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$956K Buy
10,825
+2,325
+27% +$217K 0.06% 35
2017
Q4 		$1.05M Buy
8,500
+1,000
+13% +$98K 0.04% 38
2017
Q3 		$903K Buy
+7,500
New +$679K 0.04% 39
2017
Q1 		– Sell
-2,200
Closed -$251K – 61
2016
Q4 		$251K Buy
+2,200
New +$173K 0.01% 60

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

CGOV Asset Management's WST Position: Q1 2018 in Review

CGOV Asset Management increased its West Pharmaceutical (WST) stake by 27% in Q1 2018, buying an estimated $217K and bringing the position to 10,825 shares worth $956K. The position accounts for 0.06% of the portfolio, ranked #35.

CGOV Asset Management first reported a position in WST in Q4 2016 and has held it in 4 quarters since. The position peaked at $1.05M in Q4 2017. 323 funds tracked by Wall St. Rank hold WST as of Q1 2018.

  • CGOV Asset Management held 10,825 shares of West Pharmaceutical worth $956K as of Q1 2018.
  • CGOV Asset Management bought 2,325 West Pharmaceutical shares in Q1 2018, an estimated $217K.
  • West Pharmaceutical made up 0.06% of CGOV Asset Management's portfolio in Q1 2018, its #35 holding.
  • CGOV Asset Management first reported a position in West Pharmaceutical in Q4 2016 and has held it in 4 quarters since.
  • CGOV Asset Management's West Pharmaceutical position peaked at $1.05M in Q4 2017.
  • 323 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2018.

Based on CGOV Asset Management's 13F filing for Q1 2018, filed 9 Apr 2018.